The money, which comes from companies accused of aggressively marketing and distributing prescription painkillers, is meant to tackle the addiction crisis.
‘Fourth wave’ of opioid epidemic crashes ashore, propelled by fentanyl and meth
The United States is knee-deep in what some experts call the opioid epidemic’s “fourth wave,” which is not only placing drug users at greater risk but is also complicating efforts to address the nation’s drug problem.
Publicis Health reaches $350M settlement over role in the opioid crisis
Publicis Health will also disclose thousands of internal documents detailing its work for opioid manufacturers, including Purdue Pharma, on a public website.
Records show Publix opioid sales grew even as addiction crisis prompted other chains’ pullback
An executive at Teva Pharmaceuticals flagged Publix Super Markets in October 2015 after detecting what he called in an email “serious red flags” with the grocery chain’s orders of powerful opioids.
Federal lawmakers take first steps toward oversight of $50 billion in opioid settlements
This month, Rep. Marcy Kaptur (D-Ohio) and Rep. Ashley Hinson (R-Iowa) introduced legislation that would write into law approved uses for the funds so they reach people most affected by the crisis.
The year in opioid settlements: 5 things you need to know
The money is coming from an array of companies that made, sold, or distributed prescription painkillers, including Johnson & Johnson, AmerisourceBergen, and Walgreens.
Millions in opioid settlement funds sit untouched as overdose deaths rise
Nearly a year after Montana began receiving millions of dollars to invest in efforts to combat the opioid crisis, much of that money remains untouched.
Gubernatorial candidates quarrel over glory for winning opioid settlements